Table 1.

Patients and control demographics and clinical characteristics.

		Controls	Patients
n		21	22
Sex, n (%)	f	8 (38.1%)	5 (22.7%)
	m	13 (61.9%)	17 (77.3%)
Age, median [min, Q1, Q3, max]		58 yo [27,52,64,82]	60.5 yo [28,52.2,63,74]
Month after stroke, median [min, Q1, Q3, max]			4 mo [0,1,5,17]
Stroke type, n (%)	HEM		3 (33.3%)
	ISCH		6 (66.7%)
NIH stroke scale (NIHSS), median [min, Q1, Q3, max]			Available: N = 11(50%) 10 [2,5.5,16,20]
MEC Prosody Comprehension item, median [min, Q1,Q3, max]			Available: N = 22 (100%) 9 [0,8,11,12]
MEC Prosody Repetition item, median [min, Q1, Q3, max]			Available: N = 22 (100%) 11 [7,10,12,12]
MEC Total, median [min, Q1, Q3, max]			Available: N = 22 (100%) 21 [9,18.2,22.8,24]
BDAE command execution item, median [min, Q1, Q3, max]			Available: N = 22(100%) 14 [5,14,15,19]
Audiogram left-ear, median dBHL at 1000 Hz [min, Q1, Q3, max]		0 dBHL [0,0,15,35]	Available: N = 7(31%) 20 dBHL [10,15,30,60]
Audiogram right-ear, median dBHL at 1000 Hz [min, Q1, Q3, max]		5 dBHL [0,0,20,30]	Available: N = 7(31%) 15 dBHL [5,7.5,37.5,45]
Vocal audiogram, median% detection at 40 dB [min, Q1, Q3, max]			Available: N = 13(59%) 99. % [85,94,100,100]
LAMA Sustained auditory attention score accuracy, median [min, Q1, Q3, max]			Available: N = 12(54%) 30 [29,29.8,30,30]
LAMA Sustained auditory attention reaction time (sec), median [min, Q1, Q3, max]			Available: N = 12(54%) 92.5 [63,85.8,137,192]
MBEA (Montreal Battery of Evaluation of Amusia), median [min, Q1, Q3, max]			Available: N = 13(59%) 60 [48,57,71,85]
AIRTAC2 (Auditory discrimination), median [min, Q1, Q3, max]			Available: N = 13(59%) 44 [36,42,47,48]
HADS (depression + anxiety), median [min, Q1, Q3, max]			Available: N = 13(59%) 18.5 [7,11.2,24.8,35]

N = 22 right-hemisphere stroke survivors and N = 22 age-matched controls took part in the study.

MEC, Montréal Evaluation de la Communication; BDAE, Boston Diagnostic Aphasia Examination.